Relaxis

About:

Relaxis develops medical device treatments for patients with restless legs syndrome.

Website: http://myrelaxis.com

Twitter/X: MyRelaxis

Description:

Relaxis develops medical device treatments for patients with restless legs syndrome. It improves the quality of sleep in patients with primary RLS through the use of vibratory counterstimulation. The company uses vibration to overwhelm the unpleasant RLS sensations by stimulating the nerves in the legs with real sensory signals. It has the “First in Class” - and only - device that is “indicated to improve the quality of sleep in patients with primary Restless Legs Syndrome (RLS) through the use of vibratory counterstimulation” as stated by the U.S. Food and Drug Administration. “First In Class” means it’s the very first medical device (vs. drug treatment) to improve the quality of sleep for sufferers of RLS. Sensory Medical was formed in 2009 after is CEO, Fred Burbank, M.D., began to experience symptoms of RLS. Dr. Burbank found relief from his RLS symptoms by getting out of bed, standing, and walking. Although his symptoms were gone, the physical act of standing or walking left him wide awake. Dr. Burbank postulated that a device providing counterstimulation, while in bed, would relieve his symptom and allow him to quickly return to sleep. We developed a series of test devices that allowed him to remain in bed while relieving his symptoms. This initial success with Dr. Burbank led to the development of the Symphony™ pad and completion of two clinical studies with 158 patients and resulted in FDA clearance to market the Relaxis™ Pad.

Total Funding Amount:

$10.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Clemente, California, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)myrelaxis.com

Founders:

Fred Burbank

Number of Employees:

1-10

Last Funding Date:

2015-01-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai